Nonpersistent Nanoarchitectures Enhance Concurrent Chemoradiotherapy in an Immunocompetent Orthotopic Model of HPV+ Head/Neck Carcinoma

Cisplatin chemoradiotherapy (CRT) is the established standard of care for managing locally advanced human papillomavirus‐positive head/neck carcinoma. The typically young patients may suffer serious and long‐time side effects caused by the treatment, such as dysphagia, and hearing loss. Thus, ensuri...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Advanced materials (Weinheim) 2024-07, Vol.36 (28), p.e2400949-n/a
Hauptverfasser:	Gonnelli, Alessandra, Gerbé de Thoré, Marine, Ermini, Maria Laura, Frusca, Valentina, Zamborlin, Agata, Signolle, Nicolas, Bawa, Olivia, Clémenson, Céline, Meziani, Lydia, Bergeron, Paul, El‐Azrak, Ismail, Sarogni, Patrizia, Mugnaioli, Enrico, Giannini, Noemi, Drava, Giuliana, Deutsch, Eric, Paiar, Fabiola, Mondini, Michele, Voliani, Valerio
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antineoplastic Agents - chemistry Antineoplastic Agents - therapeutic use Biocompatibility Cancer Cell Line, Tumor chemoradiotherapy Chemoradiotherapy - methods Chemotherapy Cisplatin - chemistry Cisplatin - therapeutic use Clusters combined therapy Gold - chemistry gold nanoparticles head and neck carcinoma Head and Neck Neoplasms - therapy Human papillomavirus Humans Immunocompetence Metal Nanoparticles - chemistry Metal Nanoparticles - therapeutic use Mice Nanomaterials Nanoparticles Nanostructures - chemistry Noble metals Papillomaviridae Papillomavirus Infections - therapy Radiation dosage Radiation therapy radiosensitization Side effects Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!